Fondation ARC   Report issue

Foundation Phase 2 Phase 3
Founded: Villejuif France (1962)

Organization Overview

First Clinical Trial
1999
NCT00169130
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

ARC Foundation for Cancer Research | Fondation ARC